The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 18, 2022
Filed:
Aug. 01, 2016
Applicant:
Suzhou Alphamab Co., Ltd., Jiangsu, CN;
Inventors:
Assignee:
Suzhou Alphamab Co., LTD., Jiangsu, CN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61K 39/395 (2006.01); C12N 5/10 (2006.01); C12N 15/85 (2006.01); A61P 35/00 (2006.01); A61K 45/06 (2006.01); C07K 16/30 (2006.01); A61K 47/68 (2017.01); G01N 33/574 (2006.01); A61K 39/00 (2006.01); A61N 5/10 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2827 (2013.01); A61K 39/395 (2013.01); A61K 39/3955 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); A61K 47/6849 (2017.08); A61P 35/00 (2018.01); C07K 16/28 (2013.01); C07K 16/30 (2013.01); C12N 5/10 (2013.01); C12N 15/85 (2013.01); G01N 33/574 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); A61N 5/10 (2013.01); C07K 2317/24 (2013.01); C07K 2317/30 (2013.01); C07K 2317/52 (2013.01); C07K 2317/565 (2013.01); C07K 2317/569 (2013.01); C07K 2317/72 (2013.01); C07K 2317/732 (2013.01); C07K 2317/734 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2317/94 (2013.01); C07K 2319/30 (2013.01);
Abstract
The present invention relates to the field of medical biology and discloses a single domain antibody and derivative proteins thereof against programmed death ligand (PDL1). In particular, the present invention discloses a programmed death ligand 1 (PDL1) binding molecule and the use thereof, especially the use for treating and/or preventing or diagnosing PDL1 relevant diseases such as tumor.